HCA Healthcare (HCA) FY2024 results: revenue $70.6 billion, up 8.7% on the year
HCA Healthcare, Inc. (HCA) reported revenue of $70.6 billion for fiscal 2024, the year ended 31 December 2024, up 8.7% on the year before. Net income was $5.8 billion, up 9.9%, and diluted earnings per share $22.00. The figures are the company's own, from the 10-K it filed with the SEC on 14 February 2025.
Revenue
$70.6 billion
+8.7% on the year
FY2017FY2024
Operating margin
12.1%
11.9% a year earlier
FY2017FY2024
Net income
$5.8 billion
+9.9% on the year
FY2017FY2024
Diluted EPS
$22.00
+16.0% on the year
FY2017FY2024
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Operating cash flow
10,514
9,431
8,522
+11.5%
Capital expenditure
4,875
4,744
4,395
+2.8%
Free cash flow
5,639
4,687
4,127
+20.3%
Free cash flow margin
8.0%
7.2%
6.9%
Cash from investing
-4,933
-5,317
-3,389
Cash from financing
-4,582
-4,094
-5,656
Depreciation and amortisation
3,312
3,077
2,969
+7.6%
Share-based compensation
360
262
341
+37.4%
Buybacks
6,042
3,811
7,000
+58.5%
Dividends paid
690
661
653
+4.4%
Dividend per share
$2.64
$2.40
$2.24
+10.0%
Diluted shares, weighted
262m
276m
295m
-5.3%
Shares outstanding at period end
250m
266m
277m
-5.9%
Balance sheet
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Shareholders' equity
-2,499
-1,774
-2,767
Non-controlling interest
3,054
2,834
2,694
+7.8%
Debt
43,031
39,593
38,084
+8.7%
Operating lease liabilities
1,863
1,903
1,752
-2.1%
Finance lease liabilities
624
541
579
+15.3%
Other liabilities
13,440
13,114
12,096
+2.5%
Total liabilities and equity
59,513
56,211
52,438
+5.9%
Fixed assets
29,414
27,715
25,575
+6.1%
Investments
569
477
381
+19.3%
Cash and equivalents
1,933
935
908
+106.7%
Receivables
10,751
9,958
8,891
+8.0%
Inventory
1,738
2,021
2,068
-14.0%
Other assets
15,108
15,105
14,615
+0.0%
Total assets
59,513
56,211
52,438
+5.9%
10-K for the year ended 31 December 2024, filed 14 February 2025: the filing.